Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology ; volume:11 ; number:1 ; day:7 ; month:2 ; year:2011 ; pages:1-6 ; date:12.2011
BMC neurology ; 11, Heft 1 (7.2.2011), 1-6, 12.2011
- Creator
-
Sabbagh, Marwan
- Contributor
-
Cummings, Jeffrey
SpringerLink (Online service)
- DOI
-
10.1186/1471-2377-11-21
- URN
-
urn:nbn:de:1111-2016030328805
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sabbagh, Marwan
- Cummings, Jeffrey
- SpringerLink (Online service)
Other Objects (12)
Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriers
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
Upregulation of cholinergic modulators Lypd6 and Lypd6b associated with autism drives anxiety and cognitive decline
Symptomatology
Delphi methodology for symptomatology associated with visual dysfunctions
Urbanizing with equity consideration
Dysfunctional self-talk associated with eating disorder severity and symptomatology
The use of amisulpride in schizophrenic patients with resistant symptomatology
The cholinergic synapse
Evaluation of an Internet-delivered support program for patients with bulimic symptomatology
Does Anxiety Symptomatology Affect Bullying Behavior in Children and Adolescents with ADHD?
Discrete choice under risk with limited consideration
Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriers
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
Upregulation of cholinergic modulators Lypd6 and Lypd6b associated with autism drives anxiety and cognitive decline
Symptomatology
Delphi methodology for symptomatology associated with visual dysfunctions
Urbanizing with equity consideration
Dysfunctional self-talk associated with eating disorder severity and symptomatology
The use of amisulpride in schizophrenic patients with resistant symptomatology
The cholinergic synapse
Evaluation of an Internet-delivered support program for patients with bulimic symptomatology
Does Anxiety Symptomatology Affect Bullying Behavior in Children and Adolescents with ADHD?
Discrete choice under risk with limited consideration
Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriers
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
Upregulation of cholinergic modulators Lypd6 and Lypd6b associated with autism drives anxiety and cognitive decline
Symptomatology
Delphi methodology for symptomatology associated with visual dysfunctions
Urbanizing with equity consideration
Dysfunctional self-talk associated with eating disorder severity and symptomatology
The use of amisulpride in schizophrenic patients with resistant symptomatology
The cholinergic synapse
Evaluation of an Internet-delivered support program for patients with bulimic symptomatology
Does Anxiety Symptomatology Affect Bullying Behavior in Children and Adolescents with ADHD?